CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy.
about
A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced diseaseThe host immune response in respiratory virus infection: balancing virus clearance and immunopathology.Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.Persistence in Temporary Lung Niches: A Survival Strategy of Lung-Resident Memory CD8+ T Cells.Synergistic up-regulation of CXCL10 by virus and IFN γ in human airway epithelial cells.Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infectionInterplay between modified vaccinia virus Ankara and dendritic cells: phenotypic and functional maturation of bystander dendritic cells.Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infectionDendritic cell-epithelium interplay is a determinant factor for corneal epithelial wound repair.Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and diseaseRespiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal InjuryCXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infectionHantaan virus infection induces CXCL10 expression through TLR3, RIG-I, and MDA-5 pathways correlated with the disease severityLive attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach.Comparison of in vitro toxicological effects of biomass smoke from different sources of animal dung.Respiratory syncytial virus inhibits lung epithelial Na+ channels by up-regulating inducible nitric-oxide synthase.Transient Depletion of CD169+ Cells Contributes to Impaired Early Protection and Effector CD8+ T Cell Recruitment against Mucosal Respiratory Syncytial Virus Infection.Genetic risk factors for serious infections in inflammatory bowel diseases.TLR2 Activation Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells.Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.Diverse roles for T-bet in the effector responses required for resistance to infection.Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation.RSV Infection in Human Macrophages Promotes CXCL10/IP-10 Expression during Bacterial Co-Infection.
P2860
Q21560951-231FFA4A-826F-4151-9EC5-08AD4B2B0D2EQ26766467-838B27F4-052D-4C85-9131-4CA8F94A8680Q33902330-A3F9F5D7-04DE-4DA5-A917-9D5E656F65F5Q33907800-7992E031-77C0-41F8-AD74-F9D4D505A205Q33916203-CB188213-B67F-4443-9BC6-A83B68CEF0A9Q34072674-38858F90-3B00-4FD7-A7DA-1D7FD92D4E56Q34982651-8FE9D053-2538-468C-9053-8B5085F3CD06Q35144594-94B73D4A-5913-4932-B349-0A916ADDD0A6Q35474115-505819EF-9C96-4247-BA9C-DB0CBA48F61DQ36114292-D8C4A803-7403-43E6-B799-37F8D2C598D9Q37071608-6EF1F4AC-FA2D-46FC-B663-0AB512313BE4Q37099834-8E050A9F-F960-43E8-88DD-76D3147EDF99Q37298351-4F8CFE21-7985-4108-B40D-2C74208F2861Q37322659-87C57051-AAAC-4F59-BC96-A94D26867192Q37333899-46624BF2-597A-417E-8C3A-83E646FC6121Q37375903-F88DCC9E-C9A8-404F-9E86-27F5E05C51EAQ37632276-31F0D974-2989-4258-B879-9964490FF4DCQ37692682-CFE9EB13-BEFE-4077-9C48-4F840FA95AF7Q37718362-C71EE659-D327-4140-9428-EC7B44DCC697Q38750155-F4A12027-79F0-4A55-A3C6-1FC4E17949F7Q39897567-606F597C-C76B-449B-BCCD-EFB5B9BDF7F9Q40104785-601FB63B-0ADA-405D-B609-DF076C1E4DBAQ40344947-79413297-EEAD-48A2-9A50-D2EC8F27EAA8Q40583493-B336458C-782F-4AE2-A744-1B8841897E55Q40864107-EA0AB9E3-5B51-4206-88AE-06C03EE81627Q41565237-E75E9251-09B8-4171-9998-28A52A40E262Q42929464-6D9DB5F6-0A2B-47E7-96A5-3A0912A0EF29Q45351747-D06800A0-39CF-4863-87DA-A22397143A97Q47189394-BE356459-2827-431E-AB14-DA1D7EE4B956
P2860
CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CXCL10/CXCR3-mediated response ...... menting dendritic cell and CD8
@nl
CXCL10/CXCR3-mediated response ...... ll and CD8(+) T cell efficacy.
@en
type
label
CXCL10/CXCR3-mediated response ...... menting dendritic cell and CD8
@nl
CXCL10/CXCR3-mediated response ...... ll and CD8(+) T cell efficacy.
@en
prefLabel
CXCL10/CXCR3-mediated response ...... menting dendritic cell and CD8
@nl
CXCL10/CXCR3-mediated response ...... ll and CD8(+) T cell efficacy.
@en
P2093
P2860
P356
P1476
CXCL10/CXCR3-mediated response ...... ll and CD8(+) T cell efficacy.
@en
P2093
Dennis M Lindell
Nicholas W Lukacs
Thomas E Lane
P2860
P304
P356
10.1002/EJI.200838155
P407
P577
2008-08-01T00:00:00Z